NCT05423977 2025-09-30
Study of ZV0203 in Patients With HER2-Positive Advanced Solid Tumors
Hangzhou Adcoris Biopharmacy Co., Ltd
Phase 1 Enrolling by invitation
Clinical Trials
4 trialsNCT07053904 2025-07-08
Phase I Open-Label Study of P1101 Followed by P1801 in Advanced Solid Tumors
PharmaEssentia
Phase 1 Enrolling by invitation
NCT06169579 2024-11-15
An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of ND-003 in Patients With Advanced Solid Cancers
Shenzhen NewDEL Biotech, Co., Ltd
Phase 1 Enrolling by invitation
NCT06205082 2024-03-01
A Phase I Clinical Trial to Evaluate LIT-00814 Tablets in Patients With Advanced Solid Tumor
LittDD Medicines Ltd
Phase 1 Enrolling by invitation